(Q38954343)

7 September 2017

BRAF/NRAS wild-type melanoma, NF1 status and sensitivity to trametinib (English)

1 reference

7 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243813%20AND%20SRC:MED&resulttype=core&format=json

Carla Daniela Robles-Espinoza

3 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243813%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243813%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Marco Ranzani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243813%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Constantine Alifrangis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243813%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Daniele Perna

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243813%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Ken Dutton-Regester

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243813%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Kim Wong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243813%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Mamunur Rashid

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243813%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Nicholas K Hayward

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243813%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Mathew Garnett

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243813%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

David J Adams

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243813%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

publication date

13 October 2014

1 reference

Pigment Cell & Melanoma Research

7 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243813%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243813%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243813%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

117-119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243813%20AND%20SRC:MED&resulttype=core&format=json

Targeted therapy in melanoma - the role of BRAF, RAS and KIT mutations

3 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296225

Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296225

MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296225

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296225

A landscape of driver mutations in melanoma

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296225

Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296225

Improved survival with MEK inhibition in BRAF-mutated melanoma

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296225

Systematic identification of genomic markers of drug sensitivity in cancer cells

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296225

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296225

Management of cutaneous melanoma

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296225

Comparison of responses of human melanoma cell lines to MEK and BRAF inhibitors.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296225

BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296225

21 August 2018

Identifiers

DOI

10.1111/PCMR.12316

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243813%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243813%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

PubMed publication ID

25243813

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25243813%20AND%20SRC:MED&resulttype=core&format=json